TAY THERAPEUTICS
Tay Therapeutics is a drug discovery company that develops the next generation of topical and oral therapies for inflammatory conditions.
TAY THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Health Diagnostics
Founded:
2020-01-01
Address:
Dundee, Dundee City, United Kingdom
Country:
United Kingdom
Website Url:
http://www.taytherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
1.6 M GBP
Technology used in webpage:
Euro Pound Sterling British Server Location
Similar Organizations
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
DigitalHealth.London Accelerator
The Accelerator aims to speed up development of digital innovations across health and care, and pioneer their adoption by the NHS.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Investors List
O2h Ventures
O2h Ventures investment in Seed Round - Tay Therapeutics
Meltwind Advisory
Meltwind Advisory investment in Seed Round - Tay Therapeutics
Scottish Enterprise
Scottish Enterprise investment in Seed Round - Tay Therapeutics
University of Dundee
University of Dundee investment in Seed Round - Tay Therapeutics
Wren Capital
Wren Capital investment in Seed Round - Tay Therapeutics
O2h Ventures
O2h Ventures investment in Pre Seed Round - Tay Therapeutics
Meltwind Advisory
Meltwind Advisory investment in Pre Seed Round - Tay Therapeutics
Wren Capital
Wren Capital investment in Pre Seed Round - Tay Therapeutics
Official Site Inspections
http://www.taytherapeutics.com
- Host name: 109.228.52.133
- IP address: 109.228.52.133
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Tay Therapeutics"
Tay Therapeutics – Overcoming mutations, treating disease
We turn discovery into action, advancing differentiated small molecule medicines through in-house expertise and strategic partnerships. Our therapies aim to address serious conditions …See details»
About us - Tay Therapeutics
Mark Bell is a medicinal chemist with 20 years experience working in biotech and academic settings. He co-founded Tay Therapeutics and led on the discovery of VYN201, a topical soft …See details»
Tay Therapeutics - Crunchbase Company Profile
Tay-Enable™ A platform for discovering and developing medicines that enable the body to ignore premature stop codon mutations, producing functional …See details»
Tay Therapeutics Ltd | LinkedIn
Tay Therapeutics Ltd | 957 followers on LinkedIn. Bridging discovery to translation | Tay Therapeutics is a UK based drug discovery company.See details»
Tay Therapeutics - Company Profile - Tracxn
Website: taytherapeutics.com; Email ID: *****@taytherapeutics.com; Key Metrics. Total Funding. $1.62M in 3 rounds. Latest Funding Round. Seed, Nov 01, 2021, $546K. Ranked. 468 th …See details»
Contact – Tay Therapeutics
Tay Therapeutics Limited Company number: SC651132. Email: [email protected]. Registered Address Dundee University Incubator 3 James Lindsay PlaceSee details»
Tay Therapeutics - Products, Competitors, Financials, Employees ...
Taytherapeutics.com. Overview & Products; Financials; Founded Year 2020. Stage Seed VC | Alive. Total Raised $2.17M. Last Raised $2.17M | 3 yrs ago. About Tay Therapeutics. Tay …See details»
Tay Therapeutics Ltd - Drug pipelines, Patents, Clinical trials
Taytherapeutics.com. Holding Company | 2020 | United Kingdom | taytherapeutics.com. Last update 07 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The statistics …See details»
Tay Therapeutics - Overview, News & Similar companies - ZoomInfo
View Tay Therapeutics (www.taytherapeutics.com) location in Mississippi, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Tay Therapeutics | VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Tay Therapeutics - PitchBook
Tay Therapeutics General Information Description. Operator of a biotech company intended to develop drugs for the treatment of skin diseases. The company specializes in the discovery of drugs and aims to provide an …See details»
Tay Therapeutics | Welcome to Bio-Dundee
[email protected]. Description. Delivering first in class therapies for skin disease. We specialize in the discovery of drugs, which are safe and effective, for the treatment of skin …See details»
Spinout agrees potential $50 million deal - University of Dundee
May 2, 2023 Home; Stories; Press release. Spinout agrees potential $50 million deal. Published on 2 May 2023 University of Dundee spinout company Tay Therapeutics has announced a …See details»
Dundee University spin-out wins deal worth more than £40m
May 2, 2023 A University of Dundee spin-out has won a licensing deal potentially worth more than £40 million. Tay Therapeutics has agreed a deal with VYNE Therapeutics Inc, a US …See details»
Tay Therapeutics Announces Licensing to VYNE Therapeutics of
May 2, 2023 For more information, please visit www.taytherapeutics.com or contact Tim Sparey Ph.D (Executive Chair) [email protected] (+44 (0) 7718864561). About VYNE …See details»
Science – Tay Therapeutics
Diseases modifying: Treat the underlying genetic mutation, not just the symptoms. Broad applicability: A single drug that can treat multiple indications. As we treat a class of mutation, …See details»
Tay Therapeutics, VYNE sign licensing deal for oral BET inhibitor
May 3, 2023 Tay Therapeutics, a spin-off firm from the University of Dundee in the UK, has signed a licensing deal with VYNE Therapeutics for the development of its oral bromodomain …See details»
Tay Therapeutics - Drug Discovery World (DDW)
UK company Tay Therapeutics has entered into an exclusive license agreement with US biotech VYNE Therapeutics for its oral bromodomain and extra-terminal domain (BET) inhibitor TAY-B2.See details»
Pipeline – Tay Therapeutics
TAY-B1 (Repibresib): Locally Active BET Inhibitor. TAY-B1 is a first-in-class, locally active BET bromodomain inhibitor (BRD2, BRD3, BRD4, BRDT) designed to effectively target …See details»
Press releases – Tay Therapeutics
Terms & conditions. © tay therapeutics 2024See details»